Articles > Popular publications > PR Newswire press releases > July-September 2005 > Tuesday, August 23

Article: The Center for Business Intelligence Announces the 6th Annual Forum on Phase IV Clinical Trials.

Article from:
PR Newswire
Article date:
August 23, 2005
Copyright

WOBURN, Mass., Aug. 23 /PRNewswire/ -- The Center for Business Intelligence (CBI) will hold the 6th Annual Forum on Phase IV Clinical Trials on September 19-20, 2005 at Park Hyatt in Philadelphia, PA.

This is the must-attend event for pharmaceutical companies who are conducting Phase IV studies. Outcome, a sponsor at this year's event, conducted a survey of the Phase IV 2004 participants and the study revealed that over 50% of post-marketing studies are globally implemented and 39% agreed that the biggest problem with their study is achieving patient enrollment goals. This event provides the only opportunity for clinical, medical and marketing departments, as ... 







Read all of this article with a FREE trial
















Related newspaper, magazine, and journal articles:









  




 

    

 
 
   
 


   
  
  Article: INCREASED SCRUTINY EXPECTED IN MONITORING PHASE IV ...

  
  BIOWORLD Today; 
  August 22, 2002 ;  
  
  
 
  700+ words
... ... practices regarding the tracking of Phase IV studies. Stupak said that in the drug ... companies volunteer to conduct Phase IV studies or are ordered to conduct them ... companies volunteer to conduct Phase IV studies, many times to expand a label ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Increased Scrutiny Expected In Monitoring Phase IV ...

  
  BIOWORLD Today; 
  November 4, 2009 ;  
  
  
 
  700+ words
... ... practices regarding the tracking of Phase IV studies. Stupak said that in the drug ... companies volunteer to conduct Phase IV studies or are ordered to conduct them ... companies volunteer to conduct Phase IV studies, many times to expand a label ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Growing Midwestern Clinical Research Organization Selects ...

  
  Biotech Week; 
  August 12, 2009 ;  
  
  
 
  700+ words
... ... connection with two of the CRO's Phase IV studies covering approximately 27 sites ... details were not disclosed. Phase IV studies take place after a drug has ... solutions for these important Phase IV studies," said Cornelis F. Wit ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Washington Roundup Drugmakers Failed to Keep Pledges for ...

  
  BIOWORLD Today; 
  April 25, 2008 ;  
  
  
 
  700+ words
... ... said. The FDA usually asks for Phase IV commitment studies as part of ... has entered the marketplace. Phase IV studies conducted voluntarily by manufacturers ... its own commitments related to Phase IV studies, the FDA in 2006 hired Virginia ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Post-marketing phase IV studies create ...

  
  Clinical Trials Administrator; 
  August 1, 2007 ;  
  
  
 
  700+ words
...Post-marketing phase IV studies create opportunities for clinical ... provide annual reports on certain phase IV post-marketing studies, and some ... Also called post-approval studies, phase IV research looks at how the drug is ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: FDA says most Phase IV studies "not ...

  
  Pharma Marketletter; 
  February 19, 2007 ;  
  
  
 
  700+ words
... ... have not begun and more are "delayed." Of the 1,259 pending Phase IV studies up to September 20, last year, 899 had not been initiated and 144 ... the agency is working to improve its ability to monitor and track Phase IV studies.







   
 




  




 

    

 
 
   
 


   
  
  Article: Phase IV Studies on the Rise

  
  Pharmaceutical Executive; 
  September 1, 2004 ;  
  
  
 
  395 words
... ... In recent years, FDA requested postmarketing studies 73 percent of the time. The cost: $95 million per drug. Phase IV studies are becoming the norm, says the Tufts Center for the Study of Drug Development (CSDD). Between 1998 and 2003 ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Phase IV studies overdue. (RX: ...

  
  Chain Drug Review; 
  February 17, 2003 ;  
  
  
 
  511 words
...Phase IV studies are overdue on scores of drugs approved by the Food and Drug Administration. The agency mandates that manufacturers undertake the research for data on safety and efficacy.







   
 

























 



 





 






Newsweek
Harper's Magazine
The Washington Post
Chicago Tribune
Crain's Chicago Business
PRNewswire
Pediatric News
The Nation
Advertising Age
The Economist (US)
A FREE trial gives you access to over 80 million articles!
Access over 6,500 publications with a FREE trial!


  



Find articles, research, and archives